Change of Name

Ananda Developments PLC

20 December 2024

 

20 DECEMBER 2024

ANANDA PHARMA PLC (formerly ANANDA DEVELOPMENTS PLC)

("Ananda" or the "Company") 

Change of Name

Ananda (AQSE: ANA), a Company focused on the development of cannabinoid therapies for the treatment of a range of complex conditions, is pleased to announce that it has changed its name to ANANDA PHARMA plc.

Melissa Sturgess, CEO, commented: "This name change confirms our drive to bring licensed cannabinoid medicines to patients.  We believe the best way to support patients in need and to deliver strong returns to our shareholders is via our continued commitment to the biopharmaceutical drug development pathway. The new name, Ananda Pharma, reflects this ambition.'

The new name will be reflected on AQUIS at 8.00 a.m. on 23 December 2024. The Company's ticker will stay the same : 'ANA'  and the Company's ISIN (GB00BDQPXQ60) and SEDOL (BDQPXQ6) will also remain unchanged. In order to reflect its new name, the Company's website address has been changed to www.anandapharma.co.uk. A first look at the Company's new logo and branding is available at the bottom of this RNS.

Shareholder documents of title will be unaffected by the change of name and existing share certificates should be retained and remain valid. Any new share certificates to be issued will bear the new name, ANANDA PHARMA plc.

-Ends-  

The Directors of the Company accept responsibility for the contents of this announcement. 

For further information, please contact:

ANANDA DEVELOPMENTS PLC	[phone]
	[e-mail]
Chief Executive Officer
Melissa Sturgess
Finance Director
Jeremy Sturgess-Smith
SP ANGEL CORPORATE FINANCE LLP	[phone]
Corporate Finance
Richard Morrison
Caroline Rowe
Corporate Broking
Abigail Wayne
Rob Rees
Yellow Jersey PR (media enquiries) Sarah MacLeod Charles Goodwin Zara McKinlay	[phone] [e-mail]

 https://investors.anandadevelopments.com/link/lya71r

 

END